Alibi Idiris won’t be back in the Octagon until 2027.
His suspension comes after a fight on February 21, 2026, where he tested positive for hydrochlorothiazide, a banned diuretic. This substance is on the UFC’s Prohibited List because it can mask other drugs.
On the same night he fought, he scored a unanimous decision win against Ode Osbourne in Houston. Idiris cooperated with the investigation, admitting to using the diuretic to help with weight loss. Despite his honesty, the sanction remained firm. The Texas Department of Licensing and Regulation (TDLR) took this violation seriously, emphasizing the unfair advantage it gave him in making weight.
As a result, his record now reads 10-1-1, and the win over Osbourne has been changed to a No Contest. This means Idiris will have a notable black mark in his professional journey.
Before his fight in Houston, he also faced defeat in “The Ultimate Fighter 33” finale against Joseph Morales, emphasizing the ups and downs of his career.
Expert opinions suggest that the use of diuretics can have long-lasting consequences not just for athletes’ careers but also for the integrity of the sport. According to a 2020 survey by the Journal of Sports Medicine, around 15% of fighters have admitted to using performance-enhancing drugs or substances to gain a competitive edge.
In today’s sports landscape, transparency is crucial, yet incidents like this one show the ongoing battle against doping. With social media buzzing about the implications of such actions, fans are demanding stricter penalties and more accountability to ensure fairness in the sport.
Idiris’ case serves as a reminder. Athletes must navigate the fine line between success and the regulations meant to protect the sport’s integrity.
Source link
Latest UFC/MMA News,UFC News,UFC on Paramount+
